A. Pennell

发表

A novel route to biaryls via intramolecular free radical ipso substitution reactions

W. Motherwell, A. Pennell, 1991 .

CCR2 antagonist CCX140-B provides renal and glycemic benefits in diabetic transgenic human CCR2 knockin mice.

T. Schall, I. Charo, T. Sullivan, 2013, American journal of physiology. Renal physiology.

CCR 2 antagonist CCX 140-B provides renal and glycemic benefits in diabetic transgenic human CCR 2 knockin mice

T. Schall, I. Charo, T. Sullivan, 2013 .

Characterization of CCX140-B, an orally bioavailable antagonist of the CCR2 chemokine receptor, for the treatment of type 2 diabetes and associated complications.

T. Schall, I. Charo, Daniel M. Johnson, 2012, The Journal of pharmacology and experimental therapeutics.

Design and synthesis of pyrrolidine-5,5-trans-lactams (5-oxo-hexahydro-pyrrolo[3,2-b]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease. 1. The alpha-methyl-trans-lactam template.

G. Hart, T. Haley, A. Pennell, 2000, Journal of medicinal chemistry.

The Nitro-Mannich Reaction and Its Application to the Stereoselective Synthesis of 1,2-Diamines†

H. Adams, James C. Anderson, A. Pennell, 1998 .

Tri-n-butylstannyl radical induced rearrangement of homopropargyl (but-3-ynyl) arenesulfonates: a route to novel 4-aryl-5,6-dihydro-1,2-oxathiin 2,2-dioxides

F. Ujjainwalla, W. Motherwell, A. Pennell, 1992 .

Design and synthesis of pyrrolidine-5,5-trans-lactams (5-oxohexahydropyrrolo[3,2-b]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease. 2. Potency and chirality.

Peter Ertl, James M. Woolven, P. Ertl, 2002, Journal of medicinal chemistry.

Synthesis of biaryls via intramolecular free radical ipso-substitution reactions

S. Vázquez, F. Ujjainwalla, C. Escolano, 2015 .

Stereoselective synthesis of gem-dimethyl-5,5-pyrrolidine-trans-lactam (5-oxo-hexahydropyrrolo[3,2-b]pyrrole)

A. Pennell, A. D. Borthwick, D. E. Davies, 2001 .

An improved synthesis of the strained pyrrolidine-5,5-translactam ring system

A. Pennell, A. Mason, A. D. Borthwick, 1999 .

Characterization of CCX282-B, an Orally Bioavailable Antagonist of the CCR9 Chemokine Receptor, for Treatment of Inflammatory Bowel Disease

Yu Wang, T. Schall, J. Jaén, 2010, Journal of Pharmacology and Experimental Therapeutics.

Stereochemical aspects of intramolecular palladium catalysed [3+2] cycloadditions of methylenecyclopropanes

M. Stepp, A. Slawin, M. Shipman, 1996 .

Stereochemical Aspects of Intramolecular Palladium Catalyzed (3 + 2) Cycloadditions of Methylenecyclopropanes.

M. Stepp, A. Slawin, M. Shipman, 1996 .

Pharmacokinetic and Pharmacodynamic Evaluation of the Novel CCR1 Antagonist CCX354 in Healthy Human Subjects: Implications for Selection of Clinical Dose

T. Schall, S. Miao, J. Jaén, 2011, Clinical pharmacology and therapeutics.